超敏cTnT与血栓-炎症因子的相关性及其对急性缺血性脑卒中神经功能结局的预测价值

Relationship between high-sensitivity cardiac troponin T and thrombo-inflammatory molecules and its value in predicting neurological function outcome after acute ischemic stroke

  • 摘要: 目的 探讨急性缺血性脑卒中患者血清超敏心肌肌钙蛋白T(hs-cTnT)与血栓-炎症因子的相关性,以及发病后6 h的hs-cTnT在预测神经功能结局中的价值。 方法 选择106例首发急性缺血性脑卒中患者,分别于患者发病后6 h内和72 h检测血清hs-cTnT、S100B蛋白、hs-CRP、单核细胞趋化蛋白-1(MCP-1)、血栓-炎症因子包括组织型纤溶酶原激活物(t-PA)、可溶性CD40配体(sCD40L)和P-选择素水平,并于入院时和发病后90 d,采用美国国立卫生研究院卒中量表(NIHSS)评分联合改良Rankin量表(mRS)评分对患者神经功能进行评估。根据患者发病后90 d的神经功能结局分为预后不良组和预后良好组,比较2组患者的各项指标,分析hs-cTnT与血栓-炎症因子的相关性,以及其对神经功能结局的预测价值。 结果 纳入预后不良组62例,预后良好组44例。发病后6 h内,预后不良组血清hs-cTnT、hs-CRP、MCP-1、t-PA、sCD40L水平均高于预后良好组(P均< 0.05)。发病后72 h,预后不良组血清hs-cTnT、S100B、hs-CRP、sCD40L水平均低于预后良好组(P均< 0.05)。发病后6 h内和发病后72 h,血清hs-cTnT水平与发病后72 h的hs-CRP水平呈正相关(r = 0.585,P < 0.001;r = 0.599,P < 0.001),与发病后6 h内t-PA水平呈正相关(r = 0.551,P = 0.001;r = 0.547,P = 0.002),与发病后6 h内的MCP-1 水平呈正相关(r = 0.475,P = 0.014;r = 0.462,P = 0.015)。基线NIHSS 评分 ≥8分(OR = 2.656, 95% CI 1.009 ~ 6.995,P = 0.048)、发病后6 h内hs-cTnT(OR = 6.050,95% CI 2.352 ~ 15.560,P < 0.001)、 hs-CRP(OR = 7.294,95% CI 3.285 ~ 16.195,P < 0.001)、 MCP-1(OR = 1.349,95% CI 1.002 ~ 1.818,P = 0.049)、t-PA (OR = 1.007,95% CI 1.001 ~ 2.446,P = 0.004)是神经功能预后不良的危险因素。 结论 急性缺血性脑卒中发病后6 h内的hs-cTnT升高是神经功能预后不良的预测因子,并且还与hs-CRP、t-PA和MCP-1的急性升高有关。

     

    Abstract: Objective To investigate the relationship between serum high-sensitivity cardiac troponin T (hs-cTnT), S100B, high-sensitivity C-reactive protein (hs-CRP) and thrombo-inflammation facotrs in patients with first-ever acute ischemic stroke (AIS), and evaluate the value of hs-cTnt within 6 h after AIS onset in predicting neurological outcome. Methods A total of 106 patients with first-ever AIS were enrolled. Serum hs-cTnT, S100B, hs-CRP, monocyte chemoattractant protein-1 (MCP-1), thrombus-inflammatory markers including soluble CD40 ligand (sCD40L), tissue plasminogen activator (t-PA) and P-selectin were determined within 6 h and 72 h after AIS onset. The National Institutes of Health Stroke Scale (NIHSS) score combined with the modified Rankin Scale (mRS) score were used to evaluate the prognosis of neurological outcomes upon admission and 90 d after AIS onset. All patients were divided into the poor and excellent prognosis groups according to the neurological outcomes at 90 d after AIS onset. All parameters were statistically compared between two groups. The correlation between hs-cTnT and thrombus-inflammatory molecules was analyzed. And the value of those indexes in predicting neurological outcome were statistical analysis. Results Sixty-two patients were assigned into the poor prognosis group and 44 cases into the excellent prognosis group. Within 6 h after onset, the serum levels of hs-cTnT, hs-CRP, MCP-1, tPA and sCD40L in the poor prognosis group were significantly higer than those in the excellent prognosis group (all P < 0.05). At 72 h after onset, the serum levels of hs-cTnT, S100B, hs-CRP and sCD40L in the poor prognosis group were significantly lower compared with those in the excellent prognosis group (all P < 0.05). Within 6 h and 72 h after onset, the serum level of hs-cTnT was positively correlated with the hs-CRP level at 72 h after onset (r = 0.585, P < 0.001; r = 0.599, P < 0.001), positively correlated with the t-PA level within 6 h after onset (r = 0.551, P = 0.001 and r = 0.547, P = 0.002), and positively associated with the MCP-1 level within 6 h after onset (r = 0.475, P = 0.014; r = 0.462, P = 0.015). The baseline NIHSS score ≥8 (OR = 2.656, 95% CI 1.009-6.995,P = 0.048), hs-cTnT within 6 h after onset (OR = 6.050, 95%CI 2.352-15.560, P < 0.001), hs-CRP (OR = 7.294, 95%CI 3.285-16.195, P < 0.001), MCP-1 (OR = 1.349, 95%CI 1.002-1.818, P = 0.049) and t-PA (OR = 1.007, 95%CI 0.692-2.446, P = 0.004) were the risk factors for poor neurological function. Conclusion Elevated hs-cTnT level within 6 h after onset of AIS is an independent predictor of poor neurological outcome, which is also correlated with the acute increase of hs-CRP, t-PA and MCP-1 levels.

     

/

返回文章
返回